A Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of GSK2330811 in Healthy Subjects

Clinical trial NCT02386436 · COMPLETED

Trial details

NCT number: NCT02386436
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Scleroderma, Systemic

Start date: 2015-04-21
Primary completion: 2016-04-11
Enrollment: 41

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.